Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
出版年份 2021 全文链接
标题
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 18, Pages 10161
出版商
MDPI AG
发表日期
2021-09-21
DOI
10.3390/ijms221810161
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases
- (2021) Rachayeeta Deb et al. NEUROTOXICITY RESEARCH
- Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
- (2021) Xiangpeng Ren et al. Frontiers in Neuroscience
- The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
- (2021) Johanna Michael et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
- (2021) Tapan Behl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-Administration of Gagam-Sipjeondaebo-Tang and Ibuprofen Alleviates the Inflammatory Response in MPTP-Induced Parkinson’s Disease Mouse Model and RAW264.7 Macrophages
- (2021) Sodam Won et al. Pathogens
- Expatiating the impact of anthropogenic aspects and climatic factors on long-term soil monitoring and management
- (2021) Simona Bungau et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy
- (2021) Lalita Subedi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PGC-1s in the Spotlight with Parkinson’s Disease
- (2021) Elena Piccinin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glutathione in the Brain
- (2021) Koji Aoyama INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's Disease Genetics and Pathophysiology
- (2021) Gabriel E. Vázquez-Vélez et al. Annual Review of Neuroscience
- Effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis
- (2021) Min Cheol Chang et al. CLINICAL NUTRITION
- Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
- (2021) Johan Wallin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Mechanistic approach of Peroxisome Proliferator-Activated Receptors and its subtypes on Clinical and preclinical model of Neurodegenerative disorders
- (2021) Jinu Avarachan et al. Research Journal of Pharmacy and Technology
- Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
- (2020) Bin Peng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders
- (2020) Sylwia Wójtowicz et al. NEUROCHEMICAL RESEARCH
- PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
- (2020) Sergio Rius-Pérez et al. Oxidative Medicine and Cellular Longevity
- Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
- (2020) Mónica Gómez-Benito et al. Frontiers in Pharmacology
- Role of Peroxisome Proliferated Activated Receptor gamma (PPARγ) in Different Disease States: Recent Updates
- (2020) Suvadeep Mal et al. CURRENT MEDICINAL CHEMISTRY
- Nutraceuticals in Neurological Disorders
- (2020) Rashita Makkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice
- (2020) TCS Costa et al. Journal of Neuroimmune Pharmacology
- PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease
- (2020) Meric A. Altinoz et al. MOLECULAR ASPECTS OF MEDICINE
- The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
- (2020) Chien Tai Hong et al. Nutrients
- Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
- (2020) Csaba Váradi Biology-Basel
- Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
- (2020) B. Mahalakshmi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
- (2020) Sandro Percário et al. Oxidative Medicine and Cellular Longevity
- Neuroinflammatory responses in Parkinson’s disease: relevance of Ibuprofen in therapeutics
- (2020) Ashish Singh et al. INFLAMMOPHARMACOLOGY
- Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy
- (2020) Anna K. Strosznajder et al. NEUROMOLECULAR MEDICINE
- Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease
- (2020) Sarah Dassati et al. NEUROPHARMACOLOGY
- Circuit Mechanisms of Parkinson’s Disease
- (2019) Matthew M. McGregor et al. NEURON
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study
- (2019) Dilini Rathnayake et al. BMC Neurology
- Parkinson’s Disease in Women and Men: What’s the Difference?
- (2019) Silvia Cerri et al. Journal of Parkinsons Disease
- GBA1-associated parkinsonism
- (2019) Emory Ryan et al. CURRENT OPINION IN NEUROLOGY
- DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
- (2019) Mariaelena Repici et al. Journal of Clinical Medicine
- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- The Role of LRRK2 in Neurodegeneration of Parkinson Disease
- (2018) Qin Rui et al. Current Neuropharmacology
- Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion
- (2018) Elisabeth G. Hain et al. Journal of Neuroinflammation
- Impact of ethnicity on the natural history of Parkinson disease
- (2018) Anna Sauerbier et al. MEDICAL JOURNAL OF AUSTRALIA
- Caffeine and Parkinson disease
- (2018) David G. Munoz et al. NEUROLOGY
- Effect of montelukast in experimental model of Parkinson’s disease
- (2018) Vetrivel Babu Nagarajan et al. NEUROSCIENCE LETTERS
- Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2018) Zexu Wei et al. Frontiers in Molecular Neuroscience
- Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson’s disease model
- (2018) Yujeong Lee et al. BRAIN RESEARCH
- Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
- (2018) Félix Javier Jiménez-Jiménez et al. JOURNAL OF NEUROLOGY
- Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
- (2018) Riham M. Mansour et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
- (2018) Zaza Khuchua et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease
- (2018) Meira Maria Forcelini Machado et al. Pharmacological Reports
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- The relevance of gender in Parkinson’s disease: a review
- (2017) Marina Picillo et al. JOURNAL OF NEUROLOGY
- Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease
- (2017) Patrick K.K. Yeung et al. NEUROBIOLOGY OF AGING
- Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease
- (2017) Hannah Jang et al. NEUROREPORT
- Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
- (2017) Yanqin Wang et al. PPAR Research
- Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
- (2017) Qian Gou et al. Oncotarget
- Glucocerebrosidase Mutations in Parkinson Disease
- (2017) Grace O’Regan et al. Journal of Parkinsons Disease
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Fatty acids, eicosanoids and PPAR gamma
- (2016) Rachel Marion-Letellier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
- (2016) Juan Carlos Corona et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
- (2016) Roberto Di Maio et al. Science Translational Medicine
- Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements
- (2016) Jian-Yong Wang et al. Scientific Reports
- The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
- (2016) Irum Javaid Siddiqui et al. Scientific Reports
- Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
- (2016) Lingjia Xu et al. Parkinsons Disease
- The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain
- (2016) Eduardo Maria Normando et al. Acta Neuropathologica Communications
- Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis
- (2016) Charles B. Breckenridge et al. PLoS One
- Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
- (2016) Alvaro Sanchez-Martinez et al. Scientific Reports
- Management of Parkinson׳s disease: Current and future pharmacotherapy
- (2015) Ashish Kumar Kakkar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Understanding Parkinson Disease
- (2015) Apoorva Gopalakrishna et al. JOURNAL OF NEUROSCIENCE NURSING
- Increased Risk of Parkinson Disease in Patients With Carbon Monoxide Intoxication
- (2015) Ching-Yuan Lai et al. MEDICINE
- Head injury and risk for Parkinson disease: Results from a Danish case-control study
- (2015) L. Kenborg et al. NEUROLOGY
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle
- (2015) S. Pablo Sardi et al. PROGRESS IN NEUROBIOLOGY
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- The Ubiquitin-Proteasome System in Neurodegeneration
- (2014) Chris McKinnon et al. ANTIOXIDANTS & REDOX SIGNALING
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- A PPAR-β/δ Agonist is Neuroprotective and Decreases Cognitive Impairment in a Rodent Model of Parkinson’s Disease
- (2014) Nihar Das et al. CURRENT NEUROVASCULAR RESEARCH
- mitoNEET as a novel drug target for mitochondrial dysfunction
- (2014) Werner J. Geldenhuys et al. DRUG DISCOVERY TODAY
- Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction
- (2014) Eric S. Luth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alcohol intake and risk of Parkinson's disease: A meta-analysis of observational studies
- (2014) Dongfeng Zhang et al. MOVEMENT DISORDERS
- PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
- (2014) Juan Carlos Corona et al. NEUROCHEMICAL RESEARCH
- Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
- (2014) B. Ritz et al. NEUROLOGY
- PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease
- (2014) Janaína K. Barbiero et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Mutations in theATP13A2Gene and Parkinsonism: A Preliminary Review
- (2014) Xinglong Yang et al. Biomed Research International
- Exercise: Is it a neuroprotective and if so, how does it work?
- (2013) Michael J. Zigmond et al. PARKINSONISM & RELATED DISORDERS
- Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models
- (2012) Nian Xiong et al. CRITICAL REVIEWS IN TOXICOLOGY
- In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease
- (2012) Dirk A. Ridder et al. EXPERIMENTAL NEUROLOGY
- Lipolytic Products Activate Peroxisome Proliferator-activated Receptor (PPAR) α and δ in Brown Adipocytes to Match Fatty Acid Oxidation with Supply
- (2012) Emilio P. Mottillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6
- (2012) Prachi Bajpai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
- (2012) Yu-Chang Chen et al. MOLECULAR NEUROBIOLOGY
- The Bioenergetic Status Relates to Dopamine Neuron Loss in Familial PD with PINK1 Mutations
- (2012) Rüediger Hilker et al. PLoS One
- Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
- (2012) Edward A. Lock et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Rotenone, Paraquat, and Parkinson’s Disease
- (2011) Caroline M. Tanner et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells
- (2011) P. Seibler et al. JOURNAL OF NEUROSCIENCE
- Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease
- (2011) Kunikazu Tanji et al. NEUROBIOLOGY OF DISEASE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
- (2010) Lydia Alvarez-Erviti et al. ARCHIVES OF NEUROLOGY
- Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening
- (2010) Werner J. Geldenhuys et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients
- (2010) C. Ullrich et al. Current Alzheimer Research
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
- (2010) Karen Nuytemans et al. HUMAN MUTATION
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1α enhances α-synuclein oligomerization and down regulates AKT/GSK3β signaling pathway in human neuronal cells that inducibly express α-synuclein
- (2010) Abdul Shukkur Ebrahim et al. NEUROSCIENCE LETTERS
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Professional exposure to pesticides and Parkinson disease
- (2009) Alexis Elbaz et al. ANNALS OF NEUROLOGY
- Parkinson's disease: from monogenic forms to genetic susceptibility factors
- (2009) S. Lesage et al. HUMAN MOLECULAR GENETICS
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Incidence and remaining lifetime risk of Parkinson disease in advanced age
- (2009) J. A. Driver et al. NEUROLOGY
- Molecular mechanism of PPAR in the regulation of age-related inflammation
- (2008) Jae Heun Chung et al. AGEING RESEARCH REVIEWS
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Targeting PPAR as a therapy to treat multiple sclerosis
- (2008) John J Bright et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
- (2008) Bin Xing et al. Journal of Neuroinflammation
- Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
- (2008) Payal N. Gandhi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction
- (2008) Theodore B. VanItallie METABOLISM-CLINICAL AND EXPERIMENTAL
- Peroxisome Proliferator-Activated Receptor-γin Amyotrophic Lateral Sclerosis and Huntington’s Disease
- (2008) Mahmoud Kiaei PPAR Research
- Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats
- (2007) Randy L. Hunter et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now